Mitoneet mediates TNFα-induced necroptosis promoted by exposure to fructose and ethanol

Journal of Cell Science

Volumn 127, Issue 4, 2014, Pages 896-907

  Shulga, Nataly ^a   Pastorino, John G ^a  

^a UMDNJ School of Osteopathic Medicine   (United States)

Author keywords

Ethanol; Fructose; Mitoneet; Necroptosis; TNF

Indexed keywords

ETHANOL; FRUCTOSE; MITONEET; NECROPTOSIS; TNFΑ;

ANIMALS; APOPTOSIS; CALCIUM CHANNELS; CELL LINE, TUMOR; ETHANOL; FRUCTOSE; HEPATOCYTES; IRON; IRON-BINDING PROTEINS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MEMBRANE PROTEINS; MICE; MITOCHONDRIA, LIVER; NADH, NADPH OXIDOREDUCTASES; NECROSIS; PROTEIN BINDING; PROTEIN TRANSPORT; REACTIVE OXYGEN SPECIES; STAT3 TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84894065572     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.140764     Document Type: Article

References (55)

1. Abdelmalek, M. F., Suzuki, A., Guy, C., Unalp-Arida, A., Colvin, R., Johnson, R. J., Diehl, A. M.; Nonalcoholic Steatohepatitis Clinical Research Network (2010). Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease. Hepatology 51, 1961-1971.
2. Bao, W., Rong, Y., Rong, S. and Liu, L. (2012). Dietary iron intake, body iron stores, and the risk of type 2 diabetes: a systematic review and meta-analysis. BMC Med. 10, 119.
3. Basaranoglu, M., Basaranoglu, G., Sabuncu, T. and Sentü rk, H. (2013). Fructose as a key player in the development of fatty liver disease. World J. Gastroenterol. 19, 1166-1172.
4. Botezelli, J. D., Cambri, L. T., Ghezzi, A. C., Dalia, R. A., Voltarelli, F. A. and de Mello, M. A. (2012). Fructose-rich diet leads to reduced aerobic capacity and to liver injury in rats. Lipids Health Dis. 11, 78.
5. Bu, X., Zhao, C., Wang, W. and Zhang, N. (2013). GRIM-19 inhibits the STAT3 signaling pathway and sensitizes gastric cancer cells to radiation. Gene 512, 198-205.
6. Chen, Y., Lu, H., Liu, Q., Huang, G., Lim, C. P., Zhang, L., Hao, A. and Cao, X. (2012). Function of GRIM-19, a mitochondrial respiratory chain complex I protein, in innate immunity. J. Biol. Chem. 287, 27227-27235.
7. Cho, Y. S., Challa, S., Moquin, D., Genga, R., Ray, T. D., Guildford, M. and Chan, F. K. (2009). Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell 137, 1112-1123.
8. Colell, A., García-Ruiz, C., Miranda, M., Ardite, E., Marí, M., Morales, A., Corrales, F., Kaplowitz, N. and Fernández-Checa, J. C. (1998). Selective glutathione depletion of mitochondria by ethanol sensitizes hepatocytes to tumor necrosis factor. Gastroenterology 115, 1541-1551.
9. Conlan, A. R., Paddock, M. L., Axelrod, H. L., Cohen, A. E., Abresch, E. C., Wiley, S., Roy, M., Nechushtai, R. and Jennings, P. A. (2009). The novel 2Fe-2S outer mitochondrial protein mitoNEET displays conformational flexibility in its N-terminal cytoplasmic tethering domain. Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 65, 654-659.
10. Degterev, A., Hitomi, J., Germscheid, M., Ch'en, I. L., Korkina, O., Teng, X., Abbott, D., Cuny, G. D., Yuan, C., Wagner, G. et al. (2008). Identification of RIP1 kinase as a specific cellular target of necrostatins. Nat. Chem. Biol. 4, 313-321.
11. Dekker, M. J., Su, Q., Baker, C., Rutledge, A. C. and Adeli, K. (2010). Fructose: a highly lipogenic nutrient implicated in insulin resistance, hepatic steatosis, and the metabolic syndrome. Am. J. Physiol. Endocrinol. Metab. 299, E685-E694.
12. Diehl, A. M. (1999). Effect of ethanol on tumor necrosis factor signaling during liver regeneration. Clin. Biochem. 32, 571-578.
13. Douard, V. and Ferraris, R. P. (2008). Regulation of the fructose transporter GLUT5 in health and disease. Am. J. Physiol. Endocrinol. Metab. 295, E227-E237.
14. Duprez, L., Takahashi, N., Van Hauwermeiren, F., Vandendriessche, B., Goossens, V., Vanden Berghe, T., Declercq, W., Libert, C., Cauwels, A. and Vandenabeele, P. (2011). RIP kinase-dependent necrosis drives lethal systemic inflammatory response syndrome. Immunity 35, 908-918.
15. Fletcher, L. M., Halliday, J. W. and Powell, L. W. (1999). Interrelationships of alcohol and iron in liver disease with particular reference to the iron-binding proteins, ferritin and transferrin. J. Gastroenterol. Hepatol. 14, 202-214.
16. Geldenhuys, W. J., Funk, M. O., Barnes, K. F. and Carroll, R. T. (2010). Structure-based design of a thiazolidinedione which targets the mitochondrial protein mitoNEET. Bioorg. Med. Chem. Lett. 20, 819-823.
17. Ishimoto, T., Lanaspa, M. A., Rivard, C. J., Roncal-Jimenez, C. A., Orlicky, D. J., Cicerchi, C., McMahan, R. H., Abdelmalek, M. F., Rosen, H. R., Jackman, M. R. et al. (2013). High fat and high sucrose (western) diet induce steatohepatitis that is dependent on fructokinase. Hepatology.
18. Jin, S., Ray, R. M. and Johnson, L. R. (2008). TNF-alpha/cycloheximide-induced apoptosis in intestinal epithelial cells requires Rac1-regulated reactive oxygen species. Am. J. Physiol. Gastrointest. Liver Physiol. 294, G928-G937.
19. Kohgo, Y., Ikuta, K., Ohtake, T., Torimoto, Y. and Kato, J. (2007). Iron overload and cofactors with special reference to alcohol, hepatitis C virus infection and steatosis/insulin resistance. World J. Gastroenterol. 13, 4699-4706.
20. Koul, D., Takada, Y., Shen, R., Aggarwal, B. B. and Yung, W. K. (2006). PTEN enhances TNF-induced apoptosis through modulation of nuclear factor-kappaB signaling pathway in human glioma cells. Biochem. Biophys. Res. Commun. 350, 463-471.
21. Kusminski, C. M., Holland, W. L., Sun, K., Park, J., Spurgin, S. B., Lin, Y., Askew, G. R., Simcox, J. A., McClain, D. A., Li, C. et al. (2012). MitoNEETdriven alterations in adipocyte mitochondrial activity reveal a crucial adaptive process that preserves insulin sensitivity in obesity. Nat. Med. 18, 1539-1549.
22. Lanaspa, M. A., Sanchez-Lozada, L. G., Choi, Y. J., Cicerchi, C., Kanbay, M., Roncal-Jimenez, C. A., Ishimoto, T., Li, N., Marek, G., Duranay, M. et al. (2012a). Uric acid induces hepatic steatosis by generation of mitochondrial oxidative stress: potential role in fructose-dependent and -independent fatty liver. J. Biol. Chem. 287, 40732-40744.
23. Lanaspa, M. A., Sanchez-Lozada, L. G., Cicerchi, C., Li, N., Roncal-Jimenez, C. A., Ishimoto, T., Le, M., Garcia, G. E., Thomas, J. B., Rivard, C. J. et al. (2012b). Uric acid stimulates fructokinase and accelerates fructose metabolism in the development of fatty liver. PLoS ONE 7, e47948.
24. Li, F., Ren, W., Zhao, Y., Fu, Z., Ji, Y., Zhu, Y. and Qin, C. (2012). Downregulation of GRIM-19 is associated with hyperactivation of p-STAT3 in hepatocellular carcinoma. Med. Oncol. 29, 3046-3054.
25. Lim, J. S., Mietus-Snyder, M., Valente, A., Schwarz, J. M. and Lustig, R. H. (2010). The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome. Nat. Rev. Gastroenterol Hepatol 7, 251-264.
26. Lu, H. and Cao, X. (2008). GRIM-19 is essential for maintenance of mitochondrial membrane potential. Mol. Biol. Cell 19, 1893-1902.
27. Ludwig, D. S. (2013). Examining the health effects of fructose. JAMA 310, 33-34.
28. Lufei, C., Ma, J., Huang, G., Zhang, T., Novotny-Diermayr, V., Ong, C. T. and Cao, X. (2003). GRIM-19, a death-regulatory gene product, suppresses Stat3 activity via functional interaction. EMBO J. 22, 1325-1335.
29. Lundvall, O., Weinfeld, A. and Lundin, P. (1969). Iron stores in alcohol abusers. I. Liver iron. Acta Med. Scand. 185, 259-269.
30. Lustig, R. H. (2010). Fructose: metabolic, hedonic, and societal parallels with ethanol. J. Am. Diet. Assoc. 110, 1307-1321.
31. Lustig, R. H. (2013). Fructose: it's 'alcohol without the buzz'. Adv. Nutr. 4, 226-235.
32. Okamoto, K., Mizuno, M., Nakahara, N., Natsume, A., Yoshida, J., Mori, T., Hori, S. and Kobayashi, H. (2002). Process of apoptosis induced by TNF-alpha in murine fibroblast Ltk-cells: continuous observation with video enhanced contrast microscopy. Apoptosis 7, 77-86.
33. Ouyang, X., Cirillo, P., Sautin, Y., McCall, S., Bruchette, J. L., Diehl, A. M., Johnson, R. J. and Abdelmalek, M. F. (2008). Fructose consumption as a risk factor for non-alcoholic fatty liver disease. J. Hepatol. 48, 993-999.
34. Paddock, M. L., Wiley, S. E., Axelrod, H. L., Cohen, A. E., Roy, M., Abresch, E. C., Capraro, D., Murphy, A. N., Nechushtai, R., Dixon, J. E. et al. (2007). MitoNEET is a uniquely folded 2Fe 2S outer mitochondrial membrane protein stabilized by pioglitazone. Proc. Natl. Acad. Sci. USA 104, 14342-14347.
35. Pajak, B., Gajkowska, B. and Orzechowski, A. (2005). Cycloheximide-mediated sensitization to TNF-alpha-induced apoptosis in human colorectal cancer cell line COLO 205; role of FLIP and metabolic inhibitors. J. Physiol. Pharmacol. 56 Suppl. 3, 101-118.
36. Pastorino, J. G. and Hoek, J. B. (2000). Ethanol potentiates tumor necrosis factor-alpha cytotoxicity in hepatoma cells and primary rat hepatocytes by promoting induction of the mitochondrial permeability transition. Hepatology 31, 1141-1152.
37. Roychowdhury, S., McMullen, M. R., Pisano, S. G., Liu, X. and Nagy, L. E. (2013). Absence of receptor interacting protein kinase 3 prevents ethanolinduced liver injury. Hepatology 57, 1773-1783.
38. Rutledge, A. C. and Adeli, K. (2007). Fructose and the metabolic syndrome: pathophysiology and molecular mechanisms. Nutr. Rev. 65, S13-S23.
39. Shulga, N. and Pastorino, J. G. (2012). GRIM-19-mediated translocation of STAT3 to mitochondria is necessary for TNF-induced necroptosis. J. Cell Sci. 125, 2995-3003.
40. Simcox, J. A. and McClain, D. A. (2013). Iron and diabetes risk. Cell Metab. 17, 329-341.
41. Sripetchwandee, J., Sanit, J., Chattipakorn, N. and Chattipakorn, S. C. (2013). Mitochondrial calcium uniporter blocker effectively prevents brain mitochondrial dysfunction caused by iron overload. Life Sci. 92, 298-304.
42. Tajima, S., Ikeda, Y., Sawada, K., Yamano, N., Horinouchi, Y., Kihira, Y., Ishizawa, K., Izawa-Ishizawa, Y., Kawazoe, K., Tomita, S. et al. (2012). Iron reduction by deferoxamine leads to amelioration of adiposity via the regulation of oxidative stress and inflammation in obese and type 2 diabetes KKAy mice. Am. J. Physiol. Endocrinol. Metab. 302, E77-E86.
43. Takahashi, N., Duprez, L., Grootjans, S., Cauwels, A., Nerinckx, W., DuHadaway, J. B., Goossens, V., Roelandt, R., Van Hauwermeiren, F., Libert, C. et al. (2012). Necrostatin-1 analogues: critical issues on the specificity, activity and in vivo use in experimental disease models. Cell Death Dis. 3, e437.
44. Tammineni, P., Anugula, C., Mohammed, F., Anjaneyulu, M., Larner, A. C. and Sepuri, N. B. (2013). The import of the transcription factor STAT3 into mitochondria depends on GRIM-19, a component of the electron transport chain. J. Biol. Chem. 288, 4723-4732.
45. Tirrell, T. F., Paddock, M. L., Conlan, A. R., Smoll, E. J., Jr, Nechushtai, R., Jennings, P. A. and Kim, J. E. (2009). Resonance Raman studies of the (His)(Cys)3 2Fe-2S cluster of MitoNEET: comparison to the (Cys)4 mutant and implications of the effects of pH on the labile metal center. Biochemistry 48, 4747-4752.
46. Valerio, L. G., Jr, Parks, T. and Petersen, D. R. (1996). Alcohol mediates increases in hepatic and serum nonheme iron stores in a rat model for alcoholinduced liver injury. Alcohol. Clin. Exp. Res. 20, 1352-1361.
47. Van Antwerp, D. J., Martin, S. J., Kafri, T., Green, D. R. and Verma, I. M. (1996). Suppression of TNF-alpha-induced apoptosis by NF-kappaB. Science 274, 787-789.
48. Vanlangenakker, N., Bertrand, M. J., Bogaert, P., Vandenabeele, P. and Vanden Berghe, T. (2011). TNF-induced necroptosis in L929 cells is tightly regulated by multiple TNFR1 complex I and II members. Cell Death Dis. 2, e230.
49. Verma, M., Shulga, N. and Pastorino, J. G. (2013). Sirtuin-4 modulates sensitivity to induction of the mitochondrial permeability transition pore. Biochim. Biophys. Acta 1827, 38-49.
50. Wiley, S. E., Murphy, A. N., Ross, S. A., van der Geer, P. and Dixon, J. E. (2007a). MitoNEET is an iron-containing outer mitochondrial membrane protein that regulates oxidative capacity. Proc. Natl. Acad. Sci. USA 104, 5318-5323.
51. Wiley, S. E., Paddock, M. L., Abresch, E. C., Gross, L., van der Geer, P., Nechushtai, R., Murphy, A. N., Jennings, P. A. and Dixon, J. E. (2007b). The outer mitochondrial membrane protein mitoNEET contains a novel redox-active 2Fe-2S cluster. J. Biol. Chem. 282, 23745-23749.
52. Zhang, X. and Lemasters, J. J. (2013). Translocation of iron from lysosomes to mitochondria during ischemia predisposes to injury after reperfusion in rat hepatocytes. Free Radic. Biol. Med. 63, 243-253.
53. Zhang, J., Yang, J., Roy, S. K., Tininini, S., Hu, J., Bromberg, J. F., Poli, V., Stark, G. R. and Kalvakolanu, D. V. (2003). The cell death regulator GRIM-19 is an inhibitor of signal transducer and activator of transcription 3. Proc. Natl. Acad. Sci. USA 100, 9342-9347.
54. Zuris, J. A., Harir, Y., Conlan, A. R., Shvartsman, M., Michaeli, D., Tamir, S., Paddock, M. L., Onuchic, J. N., Mittler, R., Cabantchik, Z. I. et al. (2011). Facile transfer of [2Fe-2S] clusters from the diabetes drug target mitoNEET to an apo-acceptor protein. Proc. Natl. Acad. Sci. USA 108, 13047-13052.
55. Zuris, J. A., Ali, S. S., Yeh, H., Nguyen, T. A., Nechushtai, R., Paddock, M. L. and Jennings, P. A. (2012). NADPH inhibits [2Fe-2S] cluster protein transfer from diabetes drug target MitoNEET to an apo-acceptor protein. J. Biol. Chem. 287, 11649-11655.